Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study
N. Hanania (Houston, United States of America), J. Fang (East Hanover, United States of America), L. Zhou (Morristown, United States of America), B. Ortiz (East Hanover, United States of America), A. Kavati (East Hanover, United States of America), X. Jaumont (Basel, Switzerland), L. Alvares (Basel, Switzerland), H. Cao (East Hanover, United States of America)
Source: International Congress 2018 – Eosinophils in airway disease
Session: Eosinophils in airway disease
Session type: Oral Presentation
Number: 5388
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Hanania (Houston, United States of America), J. Fang (East Hanover, United States of America), L. Zhou (Morristown, United States of America), B. Ortiz (East Hanover, United States of America), A. Kavati (East Hanover, United States of America), X. Jaumont (Basel, Switzerland), L. Alvares (Basel, Switzerland), H. Cao (East Hanover, United States of America). Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study. 5388
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: